Our knowlewdge about the genetic basis of head and neck tumours is accumulating fast. This article reviews the important advances in this area over the last decade and its implications for the future. Newer aspects of gene therapy, molecular staging and understanding head and neck carcinogenesis on a molecular level are outlined.
INTRODUCTION
T he last decade has seen an explosion in our knowledge about the molecular mechanisms involved in cancer. Head and Neck Squamous cell Carcinoma (HNSCC), accounting for about 95% of all head and neck cancers has received a lot of attention. A tumour progression model for HNSCC is rapidly emerging; one can outline how a normal upper aerodigestive tract epithelial cell undergoes malignant transformation in a series of steps.
A large number of gene and chromosome abnormalities are found in tumour cells. It is likely that malignancy results from the accumulation of about 6 to 10 independent genetic events 1. The individual pattern of these in a particular tumour determines its behaviour.
It is now clear that there are 3 main mechanisms involved in Head and Neck carcinogenesis: (a) Cellular oncogenes and oncoproteins; (b) Loss of Tumour Suppressor Gene activity through deletions or mutations and (c) Viral oncogenes which infect human cells and are incorporated into the human genome and alter cell regulatory pathways. Each of these will be reviewed in turn. Figure 1 shows the genes and products involved in HNSCC. Many more such geness have been postulated to exist in specific locations, and will be identified in the near future. This leads us to the question of the practical utility of our knowledge of molecular biology in the management of head and neck cancers. Much of current research addresses earlier diagnosis, accurate prognosis and control of cancer progression by gene therapy. Many trials have been approved and are being conducted on patients, and initial result appear promising in some cases. Clinical oncobiology, has just begun yielding its fruits.
Cellular Oncogenes, Gene Amplification and Protein Expression
Normal DNA replication and cell proliferation requires several steps 2 in sequence, beginning with the binding of growth factors (e.g. Epidermal growth factor, EGF) to there specific cell Recent Advances in the Molecular Biology of 5udip Ghosh surface receptors (e.g. EFGR). This is followed by amplified transmission of these signals by membrane-bound proteins (e.g.G-proteins, TRK-Proteins with Tyrosine Kinase activity) to the nucleus. Specific nuclear proteins (e.g. cyclins) are expressed, which activate other genes for cell division after binding to DNA. These steps are outlined in Figure 1 . 
